MBIO — MUSTANG BIO, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-08-22.
Performance
Technicals
Others in Healthcare
Measured signals that fired on MBIO
| date | signal | measured base rate |
|---|---|---|
| 2026-08-17 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-04-24 | Litchman Manuel MD President, CEO and Interim CFO | Shares withheld for tax | 19 | 0.75 | 14 |
| 2026-01-02 | Fortress Biotech, Inc. | Grant or award | 278.4K | 0.00 | 0 |
| 2025-12-30 | Herskowitz Neil Director | Open-market sale | 247 | 0.96 | 237 |
| 2025-12-30 | Jin David Director | Open-market purchase | 247 | 0.96 | 237 |
| 2025-12-30 | Chill Adam J. Director | Open-market sale | 4 | 0.95 | 4 |
| 2025-09-29 | Fortress Biotech, Inc. | Grant or award | 59.3K | 0.00 | 0 |
| 2025-04-24 | Litchman Manuel MD President, CEO and Interim CFO | Shares withheld for tax | 27 | 1.24 | 33 |
| 2025-03-31 | Fortress Biotech, Inc. | Grant or award | 67.8K | 0.00 | 0 |
| 2024-06-27 | Fortress Biotech, Inc. | Grant or award | 575.2K | 0.00 | 0 |
| 2024-05-31 | Litchman Manuel MD President and CEO | Shares withheld for tax | 1.4K | 0.35 | 489 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Kestra Advisory Services, LLC | 128.2K | 176.0K |
| GEODE CAPITAL MANAGEMENT, LLC | 67.5K | 92.8K |
| BlackRock, Inc. | 61.7K | 84.7K |
| CITADEL ADVISORS LLC | 38.7K | 53.2K |
| VANGUARD FIDUCIARY TRUST CO | 23.4K | 32.1K |
| VANGUARD CAPITAL MANAGEMENT LLC | 18.7K | 25.7K |
| CFO4Life Group, LLC | 14.9K | 20.5K |
| TWO SIGMA INVESTMENTS, LP | 12.2K | 16.8K |
| UBS Group AG | 2.7K | 3.7K |
| Tower Research Capital LLC (TRC) | 1.4K | 1.9K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about MBIO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →